Enhanced Prostate Cancer Screening at Barbican Medical Centre
- Overview
Call us to book and quote “STK99”
03452 302 040Or call us on
Reviewed on Thursday 21 May 2026 by Dr Unnati Desai, National Lead - General Practice
Our Enhanced Prostate Cancer Screening Service provides a more accurate assessment of your prostate cancer risk than a standard PSA test.
Why choose an Enhanced Prostate Cancer Screening?
Traditional prostate cancer screenings use the PSA (Prostate Specific Antigen) blood test, which measures a protein produced by the prostate. But, your PSA score alone cannot always distinguish between aggressive cancer and benign prostate conditions.
This can result in:
- Unclear results
- Unnecessary biopsies
- Missed aggressive cancers
This screening programme is currently available at our Central London location, Barbican Medical Centre, and is delivered in collaboration with Prostate Cancer Research.
Price £99
You will be invited to share your data to contribute to an important research study exploring how advanced testing can improve the early detection of prostate cancer.
- A short, simple and self-funded blood test
- An accurate and personalised prostate cancer risk score
- Earlier detection of aggressive prostate cancers
The Stockholm3 test
It combines the PSA blood test with the advanced Stockholm3 test to give a personalised risk score and a clearer, more complete picture of your overall prostate health.
What is the Stockholm3 blood test?
The Stockholm3 test is an advanced molecular test that improves risk assessment by analysing:
- PSA levels
- Additional prostate cancer biomarkers
- Genetic risk markers
- Clinical information such as age and family history
These results are analysed using a specialised algorithm to produce a personalised prostate cancer risk score.
It’s important to note that the Stockholm3 test does not diagnose prostate cancer. What it does do is indicate to your doctor whether further investigations are necessary.
| Risk level | What this means |
| Low Risk: ≤ 3% |
|
| Normal Risk: 4 - 10% |
|
| Elevated Risk: ≥ 11% |
|
Ready to find out your prostate cancer risk score
Eligibility criteria
To find out if you’re eligible for an Enhanced Prostate Cancer Screen, take a look at our inclusion and exclusion criteria below.
-
Inclusion criteria
You are eligible for our Enhanced Prostate Cancer Screen if you are:
- Assigned Male at Birth
- Are between the ages of 45 and 74 inclusive
You should consider our Enhanced Prostate Cancer Screen if you do not have any exclusions from the list below and if you:
- Are concerned about your prostate health
- Have a family history of prostate cancer
- Have concerning or unclear PSA results
- Would like a more advanced prostate cancer risk assessment prior to considering further investigations
- Are willing to self-fund the price of your screening
-
Exclusion criteria
You will not be eligible for our Enhanced Prostate Cancer Screen if you:
- Are aged under 45 or if you are aged 75 and over
- Have a current or previous history of prostate cancer
- Are currently taking gender-affirming hormone therapy (GAHT*)
*GAHT significantly reduces PSA levels which may cause false negative results in standard PSA testing and the Stockholm3 test. We recommend that patients on GAHT who wish to undergo prostate screening do so via a GP appointment to ensure appropriate thresholds are considered.
You should delay having the Stockholm3 test if any of the following apply to you as they cause temporarily elevated PSA levels:
- You have had a prostate biopsy or prostate surgery within the last 6 weeks
- You have had inflammation of the prostate within the last 6 weeks*
- You have had a digital rectal exam, instrumentation of rectum or anal sex in the last 7 days*
- You have ejaculated in the last 48 hours*
- You have engaged in vigorous exercise (intense weightlifting or cardiovascular activity) in the last 48 hours*
*You can still book the Stockholm3 test after the required amount of time has lapsed to ensure your PSA level has returned to its baseline.
When to see a GP first
If you have any of the following urinary symptoms, you should see a GP for a comprehensive assessment before booking onto our Enhanced Prostate Cancer Screening.
Whilst the Stockholm3 test can be done in both asymptomatic and symptomatic patients, accessing clinical care must be prioritised prior to testing.
These urinary symptoms include:
- Needing to pass urine more frequently
- Needing to pass urine more urgently
- Waking at night to pass urine more than once
- Difficulty in starting urination
- Weak urinary stream
- Straining when passing urine
- Dribbling at the end of passing urine
- Feeling that the bladder is not emptying
Call us to book
To book your screening call the booking line listed below and quote “STK99”. Our lines are open from 8am–8pm, Monday to Friday excluding bank holidays.